Mineralys Therapeutics (MLYS) Short Interest Ratio & Short Volume → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free MLYS Stock Alerts $14.27 -0.38 (-2.59%) (As of 04:27 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Mineralys Therapeutics Short Interest DataCurrent Short Volume872,900 sharesPrevious Short Volume850,500 sharesChange Vs. Previous Month+2.63%Dollar Volume Sold Short$10.77 millionShort Interest Ratio / Days to Cover5.1Last Record DateApril 15, 2024Outstanding Shares49,631,000 sharesFloat Size23,140,000 sharesShort Percent of Float3.77%Today's Trading Volume189,561 sharesAverage Trading Volume164,103 sharesToday's Volume Vs. Average116% Short Selling Mineralys Therapeutics ? Sign up to receive the latest short interest report for Mineralys Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMLYS Short Interest Over TimeMLYS Days to Cover Over TimeMLYS Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Mineralys Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024872,900 shares $10.77 million +2.6%3.8%5.1 $12.34 3/31/2024850,500 shares $10.98 million +1.0%4.8%5 $12.91 3/15/2024842,100 shares $10.69 million -13.5%5.8%4.9 $12.69 2/29/2024974,000 shares $14.98 million +0.9%6.7%5.5 $15.38 2/15/2024965,500 shares $14.46 million +19.1%6.6%5.2 $14.98 1/31/2024810,400 shares $8.84 million -3.2%4.3%4.3 $10.91 Get the Latest News and Ratings for MLYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024836,900 shares $7.78 million -15.5%4.4%4.8 $9.30 12/31/2023990,600 shares $8.52 million +58.5%5.2%5.8 $8.60 12/15/2023625,100 shares $5.04 million -47.9%3.3%3.6 $8.06 11/30/20231,200,000 shares $7.99 million -6.3%6.4%6.7 $6.66 11/15/20231,280,000 shares $8.68 million -9.2%6.8%6.8 $6.78 10/31/20231,410,000 shares $10.90 million -22.1%7.9%6.6 $7.73 10/15/20231,810,000 shares $16.40 million -1.1%10.2%9.7 $9.06 9/30/20231,830,000 shares $17.40 million +3.4%10.3%9.9 $9.51 9/15/20231,770,000 shares $20.37 million +18.8%9.9%8.8 $11.51 8/31/20231,490,000 shares $19.13 million +2.8%8.0%7 $12.84 8/15/20231,450,000 shares $18.08 million +25.0%7.8%7.4 $12.47 7/31/20231,160,000 shares $16.39 million +0.9%6.2%7 $14.13 7/15/20231,150,000 shares $17.85 million +12.8%7.4%7.6 $15.52 6/30/20231,020,000 shares $17.39 million +47.0%6.6%6.8 $17.05 6/15/2023693,900 shares $10.81 million +12.5%4.5%4.9 $15.58 5/31/2023616,800 shares $8.97 million -16.4%4.0%3.7 $14.54 5/15/2023738,000 shares $11.95 million No Change4.8%4.3 $16.19 MLYS Short Interest - Frequently Asked Questions What is Mineralys Therapeutics' current short interest? Short interest is the volume of Mineralys Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 872,900 shares of MLYS short. 3.77% of Mineralys Therapeutics' shares are currently sold short. Learn More on Mineralys Therapeutics' current short interest. What is a good short interest ratio for Mineralys Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MLYS shares currently have a short interest ratio of 5.0. Learn More on Mineralys Therapeutics's short interest ratio. What is a good short interest percentage for Mineralys Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.77% of Mineralys Therapeutics' floating shares are currently sold short. Is Mineralys Therapeutics' short interest increasing or decreasing? Mineralys Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 872,900 shares, an increase of 2.6% from the previous total of 850,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Mineralys Therapeutics' float size? Mineralys Therapeutics currently has issued a total of 49,630,000 shares. Some of Mineralys Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mineralys Therapeutics currently has a public float of 23,140,000 shares. How does Mineralys Therapeutics' short interest compare to its competitors? 3.77% of Mineralys Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Mineralys Therapeutics: AnaptysBio, Inc. (18.01%), Dianthus Therapeutics, Inc. (8.87%), Wave Life Sciences Ltd. (2.58%), Nurix Therapeutics, Inc. (14.32%), Nuvation Bio Inc. (2.37%), Bicycle Therapeutics plc (9.85%), Savara Inc (4.96%), Phibro Animal Health Co. (3.10%), Disc Medicine, Inc. (14.90%), Aurinia Pharmaceuticals Inc. (8.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Mineralys Therapeutics stock? Short selling MLYS is an investing strategy that aims to generate trading profit from Mineralys Therapeutics as its price is falling. MLYS shares are trading up $0.48 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mineralys Therapeutics? A short squeeze for Mineralys Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MLYS, which in turn drives the price of the stock up even further. How often is Mineralys Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MLYS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ANAB Short Interest DNTH Short Interest WVE Short Interest NRIX Short Interest NUVB Short Interest BCYC Short Interest SVRA Short Interest PAHC Short Interest IRON Short Interest AUPH Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MLYS) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders